As of 2025-11-17, the Intrinsic Value of Advanced Oncotherapy PLC (AVO.L) is -37.88 GBP. This AVO.L valuation is based on the model Peter Lynch Fair Value. With the current market price of 1.93 GBP, the upside of Advanced Oncotherapy PLC is -2,067.79%.
Based on its market price of 1.93 GBP and our intrinsic valuation, Advanced Oncotherapy PLC (AVO.L) is overvalued by 2,067.79%.
Note: result may not be accurate due to the invalid valuation result of Peter Lynch's fair value model.
| Range | Selected | Upside | |
| a | |||
| Fair Value | -37.88 - -37.88 | -37.88 | -2,067.79% |
| P/E | (138.64) - (153.04) | (144.89) | -7626.8% |
| DDM - Stable | (18.38) - (62.15) | (40.26) | -2191.6% |
| DDM - Multi | (0.21) - (0.52) | (0.29) | -115.1% |
| Market Cap (mil) | 10.41 |
| Beta | 0.23 |
| Outstanding shares (mil) | 5.41 |
| Enterprise Value (mil) | 67.64 |
| Market risk premium | 5.98% |
| Cost of Equity | 23.91% |
| Cost of Debt | 5.00% |
| WACC | 7.96% |